Search Contact

Nortem BioGroup lists on Euronext Access Paris

Back

  • Market capitalisation of €12.89 million
  • 8th listing of a Spanish issuer on Euronext in 2023
  • 10th international listing on Euronext in 2023
  • 46th listing on Euronext in 2023

Paris – 27 September 2023 – Euronext today congratulates Nortem BioGroup, a food technology company specialising in the development of functional supplements and products, on its listing on Euronext Access Paris (ticker code: MLBIO).

Nortem BioGroup is a Spanish holding company that currently operates five different brands of food products using natural ingredients: Nortembio, NaturalPharma Laboratories, Luxury & Grace, Ecodescalk and LG Health iSystems. Nortem sells its catalogue of products online to more than half a million consumers. Over 70% of Nortem BioGroup’s products are certified organic and meet the highest standards of quality and food safety, as well as CAAE and Euroleaf certifications, among others.

Nortem BioGroup’s listing on Euronext Access Paris was completed through the admission to trading on 27 September 2023 of its 2,578,500 ordinary shares, through the technical listing procedure. The reference price was set at €5.00 per share. Market capitalisation was approximately €12.89 million on the day of listing.

José Luis Vázquez, Founder and President at Nortem BioGroup, said: “The listing on Euronext  is an important milestone for Nortem BioGroup. This strengthens our position as a leader in the food technology segment and enables us to further develop our vision of promoting human well-being through food products and supplements. We are proud of our growth and commitment to quality, and this new phase will allow us to step up our investment in research and development and continue to offer to our consumer innovative and high-quality products”.

Nortem BioGroup bell ceremony

​Caption: José Luis Vázquez, Founder and President at Nortem BioGroup, and his team rang the bell during a ceremony this morning, in the presence of Jérôme Hervé, Listing Director France at Euronext, to celebrate the listing of the company.

About Nortem BioGroup

Nortem BioGroup is an Andalusian food technology company specialising in the development of functional supplements and products to improve the health and quality of life of its customers. Nortem is a holding company that currently operates five different brands of food products using natural ingredients: Nortembio, NaturalPharma Laboratories, Luxury & Grace, Ecodescalk and LG Health iSystems.

Nortem sells its catalogue of products online to more than half a million consumers. The company posted revenues of more than €7 million last year, mainly through Amazon. 70% of its products are certified organic and meet the highest standards of quality and food safety, as well as CAAE and Euroleaf certifications, among others.

More than 30% of the company's turnover is spent on R&D, done at the company's 5,000 square metre facility in Puerto de Santa María and which will be expanded in the coming months. Today, the company has a team of 35 specialists, 20% of whom are dedicated to R&D.          

 

 

Dowload PR - Nortem BioGroup lists on Euronext Access Paris

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway, and Portugal. As of March 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway, and Portugal host nearly 1,800 listed issuers with around €6.3 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices. 
For the latest news, follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2025, Euronext N.V. - All rights reserved.